Bio-Path Holdings
  • About Bio-Path
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Partnering Opportunities
  • Technology
  • Pipeline
    • Pipeline
    • Prexigebersen
    • BP1001-A
    • BP1002
    • BP1003
  • Patients
  • Investors
    • Overview
    • SEC Filings
    • Corporate Governance
  • Media
    • Press Releases
    • Events
    • Presentations & Publications
  • Careers
  • Contact Us

Bio-Path Holdings to Present Data at 2016 American Society of Clinical Oncology Annual Meeting

BPTH_ASCO2016

Bio-Path Holdings Reports First Quarter 2016 Financial Results

BPTH_PR_20160511

Bio-Path Holdings to Present at 18th Annual TIDES: Oligonucleotide and Peptides Therapeutic Conference

BPTH_TIDES_20160505

Bio-Path Holdings to Announce First Quarter 2016 Financial Results on May 11, 2016

BPTH Press Release

OncLive interview with Dr. Cortes on BP-100.01 in Patients with Relapsed/Refractory AML

Interview

Bio-Path Hopes to Blaze Profitable Path With Antisense Drugs – January 2016

ATI_Biopath_1-25-16_000

Pre-approval Access Policy

Bio-Path Holdings Announces Research Collaboration on Autoimmune Indication with The University of Texas Southwestern Medical Center

BPTH_UTSW_collaboration

Bio-Path Holdings Reports Fiscal Year 2015 Operational and Financial Results

BPTH_FY_2015

Bio-Path Holdings Announces Pancreatic Cancer Research Collaboration with Leading Oncology Institution

BPTH_MDACC_pancreatic20160308

Bio-Path Holdings

All Rights Reserved

Office:

4710 Bellaire Blvd, Suite 210
Bellaire, TX 77401

T: (832) 742-1357

R&D:

5455 Dashwood Street, Suite 300
Bellaire, TX 77401

T: (832) 742-1357

logo
  • About Bio-Path
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Partnering Opportunities
  • Technology
  • Pipeline
    • Pipeline
    • Prexigebersen
    • BP1001-A
    • BP1002
    • BP1003
  • Patients
  • Investors
    • Overview
    • SEC Filings
    • Corporate Governance
  • Media
    • Press Releases
    • Events
    • Presentations & Publications
  • Careers
  • Contact Us